Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue

Eli Lilly ends COVID-19 antibody trial in hospitalised setting, other studies continue

Lilly initially paused the US National Institute of Allergy and Infectious Diseases (NIAID) partnered study earlier this month. ... This could result in the neutralising antibody having less benefit in hospitalised COVID-19 patients, Lilly added.

Independent consultant will review Lilly’s COVID-19 plant issues

Independent consultant will review Lilly’s COVID-19 plant issues Last week, Lilly paused a clinical trial of its COVID-19 antibody treatment due to a potential safety concern. ... At that time, an independent data safety monitoring board (DSMB) recommended that Lilly pause enrolment of the ACTIV-3 study.

Lilly buys biotech firm Disarm Therapeutics for $135m

Lilly buys biotech firm Disarm Therapeutics for $135m Once the acquisition is completed, Lilly will have access to Disarm’s arsenal of SARM1 inhibitors and will be able to advance them into preclinical and clinical development. ... The scientific team at Disarm discovered an important and highly promising

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

Biopharma industry encouraged by EMA’s COVID-19 transparency measures Eli Lilly also announced a study pause this week for its COVID-19 antibody treatment, after an independent data and safety monitoring board (DSMB) highlighted a potential safety issue.

Eli Lilly’s COVID-19 antibody trial paused due to safety issue

Eli Lilly’s COVID-19 antibody trial paused due to safety issue In a statement Molly McCully, a spokeswoman for Lilly, said: “Safety is of the utmost importance to Lilly […] Lilly is supportive of the decision by the independent Data and Safety Monitoring ... Lilly has since confirmed the OAI notice but said that

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics